PI3KCA Peptide
€100.00
In stock
SKU
350481
Protein Family: Enzymes, Protein Kinases
Pathway and Disease: Carbohydrate Metabolism, Cell Communication, Cell Growth and Death, Cell Motility, Endocrine System, Immune System, Signal Transduction
Alternate Names: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3-kinase p110 subunit alpha; PtdIns-3-kinase p110; PI3K; PIK3CA
Accession No.: P42336, NP_006209
Description:
PIK3CA, a PI3/PI4 kinase, phosphorylates PtdIns, PtdIns4P and PtdIns(4,5)P2 with a preference for PtdIns(4,5)P2. Defects in PIK3CA are associated with colorectal, breast and epithelial ovarian cancers.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 2223.4 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200119 is selected from a sequence within the C-term region of human PI3KCA. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C93H143N23O34S3
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Pathway and Disease: Carbohydrate Metabolism, Cell Communication, Cell Growth and Death, Cell Motility, Endocrine System, Immune System, Signal Transduction
Alternate Names: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3-kinase p110 subunit alpha; PtdIns-3-kinase p110; PI3K; PIK3CA
Accession No.: P42336, NP_006209
Description:
PIK3CA, a PI3/PI4 kinase, phosphorylates PtdIns, PtdIns4P and PtdIns(4,5)P2 with a preference for PtdIns(4,5)P2. Defects in PIK3CA are associated with colorectal, breast and epithelial ovarian cancers.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 2223.4 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200119 is selected from a sequence within the C-term region of human PI3KCA. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C93H143N23O34S3
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review